Cite
HARVARD Citation
Luminari, S. et al. (n.d.). A phase II study of bendamustine in combination with rituximab as initial treatment for patients with indolent non-follicular non-Hodgkin lymphoma. Leukemia & lymphoma. 57 (4), pp. 880-887. [Online].